The effects of oral clarithromycin on airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD) - a double blind randomised controlled trial

D. Banerjee, S. Hussain, O. Khair, D. Honeybourne (Birmingham, United Kingdom)

Source: Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Session: Assessment and monitoring of inflammation in COPD and asthma
Session type: Poster Discussion
Number: 2239
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Banerjee, S. Hussain, O. Khair, D. Honeybourne (Birmingham, United Kingdom). The effects of oral clarithromycin on airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD) - a double blind randomised controlled trial. Eur Respir J 2001; 16: Suppl. 31, 2239

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of moxifloxacin for treatment of bronchial colonisation in COPD patients: a randomised, double-blind, placebo-controlled study
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007



Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial
Source: Eur Respir J 2002; 19: 936-943
Year: 2002



Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.
Source: Eur Respir J 2002; 20: 245
Year: 2002


Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
Source: Eur Respir J 2003; 21: 68-73
Year: 2003



Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial
Source: Eur Respir J, 50 (1) 1601448; 10.1183/13993003.01448-2016
Year: 2017



The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


A single centre double-blind placebo controlled pilot study into the use of intravenous magnesium sulphate for the treatment of acute exacerbation of chronic obstructive airways disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Effects of combined therapy with nebulized b2-agonist and anticholinergic in severe exacerbation of chronic obstructive pulmonary disease. Randomized controlled trial
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Source: Eur Respir J 2007; 29: 906-913
Year: 2007



Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study
Source: Eur Respir J 2004; 24: Suppl. 48, 243s
Year: 2004

Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Non-invasive positive pressure ventilation (NIPPV)for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 403s
Year: 2003

A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


The effects of atorvastatin in mustard gas exposed patients with chronic obstructive pulmonary disease: A randomized controlled trail
Source: Annual Congress 2012 - COPD beyond tobacco
Year: 2012


Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with chronic obstructive pulmonary disease (COPD): a double-blind placebo-controlled, parallel-group quantitative study of bronchial biopsies
Source: Eur Respir J 2001; 18: Suppl. 33, 338s
Year: 2001

Interval exercise for patients with severe COPD – randomised trial [SRCTN11611768]
Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation
Year: 2006


Creatine supplementation and physical training in patients with COPD. A double blind, placebo-controlled study
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006


A multicentre randomised controlled trial of inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study)
Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease
Year: 2017